Ashwin Sapra is a Partner in Trilegal’s Corporate practice and is recognised as a leading pharmaceutical and healthcare lawyer in India, with over 25 years of experience advising on complex regulatory, transactional and contentious matters. He advises multinational corporations, leading Indian companies and healthcare institutions on India’s regulatory framework governing pharmaceuticals, medical devices, diagnostics, nutraceuticals and related products.

His expertise spans the product lifecycle, including clinical trials, market entry, pricing and price control, promotional practices and post-market compliance. Ashwin also advises on highvalue M&A, private equity and capital markets transactions, including regulatory due diligence, approval frameworks and compliance risks in cross-border deals.

A seasoned litigator, he represents clients in disputes involving product liability, regulatory enforcement, pricing actions, recalls and government procurement before courts, tribunals and regulators across India. He also advises on ethical compliance, anti-bribery frameworks and healthcare industry codes. A recognised thought leader, Ashwin regularly speaks on legal and policy developments affecting the healthcare and life sciences sector.